Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Thrombocytopenia 8Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Leukemia 4Purpura, Thrombocytopenic, Idiopathic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Jacobs syndrome 2Sarcoma 1Primary Myelofibrosis 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Healthy Volunteers 1Healthy Adults 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Epoetin Alfa 43Darbepoetin alfa 33epoetin beta 10ferric carboxymaltose 6Cyclosporine 4Cisplatin 4ferrous sulfate 3Radiotherapy 3Lenalidomide 3peginesatide 2luspatercept 2hematide 2fludarabine 2ferric gluconate 2continuous erythropoietin receptor activator 2Therapeutics 2Filgrastim 2Erythropoietin 2Dexamethasone 2Cyclophosphamide 2Brachytherapy 2Antilymphocyte Serum 2ACE-011 2thymoglobulin 1ruxolitinib 1roxadustat 1reolysin 1pegfilgrastim 1obinutuzumab 1leridistim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia × eltrombopag × Clear all
NCT01772420 2023-07-27

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Albert Einstein College of Medicine

Phase 2 Completed
52 enrolled 21 charts
Classical hematologyOther hematologic neoplasm

Anemia, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡